News Center

位置：

Honors Announcement

Group News

Media Reports

Digital Transformation Empowers Enterprise Development Toward New Heights and Greater Excellence: A Brief Account of the First Stop of Cangzhou City’s On-Site Conference on Promoting Digital Transformation in the Manufacturing Sector—A Visit to Guangxiang Pharmaceutical

Category:

Group News

发布时间：2026-01-21

【概要描述】 In the bitter cold of the “four-nines” winter, the biting wind could not dampen the enthusiasm across Cangzhou City for the digital transformation of its manufacturing sector. On January 17, a field observation delegation led by top municipal government officials and comprising representatives from relevant government departments and heads of manufacturing enterprises made its inaugural stop at Hebei Guangxiang Pharmaceutical Co., Ltd., part of Shijiazhuang Sihua Pharmaceutical Group, where they personally witnessed the vibrant momentum that digital transformation has brought to the company.

Digital Transformation Empowers Enterprise Development Toward New Heights and Greater Excellence: A Brief Account of the First Stop of Cangzhou City’s On-Site Conference on Promoting Digital Transformation in the Manufacturing Sector—A Visit to Guangxiang Pharmaceutical

In the bitter cold of the “four-nines” winter, the biting wind could not dampen the enthusiasm across Cangzhou City for the digital transformation of its manufacturing sector. On January 17, a field observation delegation led by top government officials from Cangzhou—comprising representatives from relevant government departments and heads of manufacturing enterprises—made its inaugural stop at Hebei Guangxiang Pharmaceutical Co., Ltd., part of Shijiazhuang Sihua Pharmaceutical Group, to witness firsthand the vibrant momentum that digital transformation has brought to the company.

In the central control room of Guangxiang Pharmaceutical, members of the observation delegation paused before the massive DCS (Distributed Control System) display, where streams of data pulsed like a heartbeat, silently linking every production stage in the plant. The ever-changing curves and charts vividly depicted every detail of the manufacturing process in real time. Zhang Zanyuan, General Manager of Guangxiang Pharmaceutical, pointed to the large screen and explained: “This is the digital and intelligent fully automated management platform we have built for active pharmaceutical ingredients. By deeply integrating process control, data acquisition, and the automation control system, we have achieved systematic and integrated process management.”

“If the central control room is the brain, then each production workshop is an intelligent body that executes precise operations in response to commands, vividly exemplifying the ‘one-click’ smart manufacturing model. Zhang Zanyuan explained: ‘Relying on the intelligent DCS system, equipment processes massive amounts of data in real time, rapidly extracts key information, and enables intelligent resource management and refined operations.’”

During the on-site presentation, the most striking detail was the contrast between past and present: in the past, a single production line often required multiple “seasoned” workers to rely on their experience for frequent adjustments; today, from raw-material feeding to finished-product discharge, most stages are handled by automated, digital processes—precise and highly efficient.

In addition, the digital platform for production safety integrates key safety elements—such as the “dual-control” mechanism of risk-based tiered management and hazard identification and remediation, as well as predictive equipment maintenance—into a unified digital network. This means that every alert is no longer dependent on human eyes or judgment; instead, the system makes proactive decisions based on real-time data—precisely the most vivid illustration of the intelligent transformation of production safety.

Among the onlookers, people frequently raised their smartphones to capture the fleeting moments when the charts shifted and evolved. As industrial operations were translated into the most intuitive language of numbers, a quiet vision of the industry’s transformation toward the future began to take shape in the hearts of every observer.

“Our production efficiency has increased by more than 40%, and both production and management costs have been significantly reduced, providing strong impetus for the company’s transformation toward intelligent, green, and integrated operations. Today, our flagship product—caffeine—is exported to over 60 countries and regions worldwide.” This remarkable achievement has drawn widespread admiration from the many business representatives in attendance. When green processes are deeply integrated with digital control systems, the benefits extend far beyond enhanced capacity and efficiency: Guangxiang Pharmaceutical has obtained Cangzhou City’s first carbon footprint certification, the European Pharmacopoeia Certificate of Suitability (CEP) for caffeine, and the Authorized Economic Operator (AEO) certification from customs—each of these not only underscores the company’s commitment to social responsibility but also serves as a crucial “entry ticket” to international markets.

Meanwhile, a string of prestigious accolades—including National Green Factory, Hebei Province Advanced-Level Smart Factory, and Hebei Province Industrial Internet Benchmark Demonstration Enterprise—serve not merely as labels but as compelling evidence of Guangxiang Pharmaceutical’s tangible achievements in accelerating its digital transformation. As one visiting entrepreneur remarked: “What we see here goes far beyond smart systems and equipment; it is an integrated transformation framework that spans R&D, production, management, safety, and logistics. Such exploration and practical implementation offer valuable lessons for us.”

The question of where to begin and how to align efforts with local conditions to advance the high-quality, high-end development of manufacturing has been addressed through this “framework-setting” observation tour, which goes far beyond a mere showcase of best practices at benchmark enterprises. By drawing on cutting-edge ideas and core pathways for the deep integration of digital technologies with the real economy, the initiative aims to stimulate endogenous momentum for high-quality manufacturing development and drive a profound transformation in both development philosophy and practical models.

Guangxiang Pharmaceutical’s experience demonstrates that high-quality, high-end development in the manufacturing sector must be driven by digitalization, embedding technological applications as systemic capabilities across the enterprise and thereby enabling a comprehensive reconfiguration of its development model. This, perhaps, is the most fundamental demonstration value of the “Guangxiang Approach.” Zhang Zanyuan, General Manager of Guangxiang Pharmaceutical, stated that while deepening its R&D efforts in high-end active pharmaceutical ingredients, the company is actively advancing the intelligent transformation of its entire industrial chain, leveraging this initiative to foster collaborative transformation among upstream and downstream partners.

Through the interplay of light and shadow reflected on the screens in the central control room, what people see is not only the present state of a benchmark enterprise, but also the courage and imagination required for an entire city—and an entire industry—to embrace change, strive for excellence, and welcome the arrival of spring. Guangxiang Pharmaceutical’s pioneering efforts are like the very first “spring shoots” breaking through frozen soil; each such transformative endeavor is reshaping and redefining the new logic for future industrial innovation, iteration, and transformation and upgrading. It is easy to foresee that, guided by these “spring shoots,” more and more blossoms of transformation will emerge, collectively painting a vibrant picture of a thriving spring for intelligent manufacturing.

Keywords:

The School of Materials Science and Engineering at Changzhou University Conducts “Enterprise Visits, Job Expansion, and Employment Promotion” Activities at Shijiazhuang Sihua Pharmaceutical Group’s Bosheng Medical Devices Co., Ltd.

Mobilizing Full Production Capacity to Strive for a Strong Start